Japanese IP-TN Trial

NCT02831569 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: Loxoprofen sodium
DRUG: Methocarbamol

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]